These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25781707)

  • 21. Container residue after activated charcoal administration in the emergency department.
    Harchelroad F
    Vet Hum Toxicol; 1992 Feb; 34(1):13-4. PubMed ID: 1621355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital.
    Berg MJ; Rose JQ; Wurster DE; Rahman S; Fincham RW; Schottelius DD
    Ther Drug Monit; 1987; 9(1):41-7. PubMed ID: 3554627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro adsorption of sodium pentobarbital by SuperChar, USP and Darco G-60 activated charcoals.
    Curd-Sneed CD; Parks KS; Bordelon JG; Stewart JJ
    J Toxicol Clin Toxicol; 1987; 25(1-2):1-11. PubMed ID: 3586080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards an improved understanding of drug excipient interactions to enable rapid optimization of nanosuspension formulations.
    Ferrar JA; Sellers BD; Chan C; Leung DH
    Int J Pharm; 2020 Mar; 578():119094. PubMed ID: 32006625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug adsorption efficacy and palatability of a novel charcoal cookie formulation.
    Klein-Schwartz W; Doyon S; Dowling T
    Pharmacotherapy; 2010 Sep; 30(9):888-94. PubMed ID: 20795844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug adsorption onto activated charcoal as a means of formulation.
    Roivas L; Neuvonen PJ
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):367-72. PubMed ID: 7934316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of medicinal carbon tablets by modified wet compression method.
    Miyachi M; Onishi H; Yumoto T; Machida Y
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1333-8. PubMed ID: 19832633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sorbitol on the phosphate adsorptive capacity of ferrihydrite suspensions.
    Gruenhagen SE; Schulze DG; Chansiri G; Hem KJ; White JL; Hem SL
    Pharm Dev Technol; 1997 Feb; 2(1):81-6. PubMed ID: 9552433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of particle size on the adsorption of theophylline onto activated charcoal, in vitro study.
    Nakamura T; Kawasaki N; Matsumoto K; Tanada S
    Chudoku Kenkyu; 2003 Jan; 16(1):57-62. PubMed ID: 12712543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption of sodium pentobarbital by three types of activated charcoal.
    Curd-Sneed CD; McNatt LE; Stewart JJ
    Vet Hum Toxicol; 1986 Dec; 28(6):524-6. PubMed ID: 3788031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and evaluation of medicinal carbon oral films.
    Sakuda Y; Ito A; Sasatsu M; Machida Y
    Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):454-7. PubMed ID: 20410622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of thermodynamic parameters for the activated charcoal-phenobarbitone adsorption system.
    Agarwal S; Pal TK
    Boll Chim Farm; 1999 Sep; 138(8):422-6. PubMed ID: 10622108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
    Casas M; Aguilar-de-Leyva Á; Caraballo I
    Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incompatibility of croscarmellose sodium with alkaline excipients in a tablet formulation.
    Bindra DS; Stein D; Pandey P; Barbour N
    Pharm Dev Technol; 2014 May; 19(3):285-9. PubMed ID: 23528069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
    Mostafa HF; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of ciprofloxacin in simulated digestive media by activated charcoal entrapped within zinc-pectinate beads.
    Khoder M; Tsapis N; Huguet H; Besnard M; Gueutin C; Fattal E
    Int J Pharm; 2009 Sep; 379(2):251-9. PubMed ID: 19467304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of activated charcoal products for the treatment of poisonings.
    McFarland AK; Chyka PA
    Ann Pharmacother; 1993 Mar; 27(3):358-61. PubMed ID: 8453175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on development of insoluble drugs as pharmaceutical suspensions by response surface methodology.
    Khattab IS
    Pharmazie; 2008 Oct; 63(10):726-30. PubMed ID: 18972834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality by design case study: an integrated multivariate approach to drug product and process development.
    Huang J; Kaul G; Cai C; Chatlapalli R; Hernandez-Abad P; Ghosh K; Nagi A
    Int J Pharm; 2009 Dec; 382(1-2):23-32. PubMed ID: 19664698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.